Skip to main content
. 2020 Jan 21;8:e8252. doi: 10.7717/peerj.8252

Table 1. MEX3A mRNA expression and clinical characteristics in liver cancer patients.

Characteristics Number of pts(%)
Age
<55 117(31.45)
>=55 255(68.55)
NA 1(0.00)
Gender
Female 121(32.44)
Male 252(67.56)
Histological_type
Fibrolamellar Carcinoma 3(0.8)
Hepatocellular Carcinoma 363(97.32)
Hepatocholangiocarcinoma (Mixed) 7(1.88)
Histologic_grade
G1 55(14.75)
G2 178(47.72)
G3 123(32.98)
G4 12(3.22)
NA 5(1.34)
Stage
I 172(46.11)
II 87(23.32)
III 85(22.79)
IV 5(1.34)
NA 24(6.43)
T_classification
T1 182(48.79)
T2 95(25.47)
T3 80(21.45)
T4 13(3.49)
TX 1(0.27)
NA 2(0.54)
N_classification
N0 253(67.83)
N1 4(1.07)
NX 115(30.83)
NA 1(0.27)
M_classification
M0 267(71.58)
M1 4(1.07)
MX 102(27.35)
Radiation_therapy
No 340(91.15)
Yes 8(2.14)
NA 25(6.7)
Residual_tumor
R0 326(87.4)
R1 17(4.56)
R2 1(0.27)
RX 22(5.9)
NA 7(1.88)
Vital_status
Deceased 130(34.85)
Living 243(65.15)
Relapse
No 179(55.94)
Yes 141(44.06)
NA 53(14.2)
MEX3A
High 117(31.37)
Low 256(68.63)

Notes.

NA, not available.